Aspen Pharmacare Holdings Limited (APN.JO)
ZAc 16886.0
(1.41%)
ZAc 16886.0
(1.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 44.7 Billion | 40.7 Billion | 38.6 Billion | 37.76 Billion | 38.64 Billion | 38.87 Billion |
| Cost of Revenue | 25.25 Billion | 22.3 Billion | 20.3 Billion | 19.97 Billion | 19.31 Billion | 19.17 Billion |
| Gross Profit | 19.45 Billion | 18.4 Billion | 18.3 Billion | 17.78 Billion | 19.33 Billion | 19.69 Billion |
| Operating Expenses | 12.41 Billion | 9.46 Billion | 9.46 Billion | 8.59 Billion | 10.36 Billion | 10.33 Billion |
| Selling, General and Administrative Expenses | 10.1 Billion | 4.59 Billion | 4.39 Billion | 4.92 Billion | 5.03 Billion | 5.17 Billion |
| Research and Development Expenses | 162 Million | 214 Million | 433 Million | 260 Million | 195 Million | 211 Million |
| Other Expenses | 2.15 Billion | - | 5.07 Billion | 3.67 Billion | 5.33 Billion | 5.16 Billion |
| Cost and Expenses | 37.7 Billion | 31.76 Billion | 29.76 Billion | 28.57 Billion | 29.68 Billion | 29.5 Billion |
| Operating Income | 6.99 Billion | 7.82 Billion | 8.67 Billion | 7.07 Billion | 7.06 Billion | 4.8 Billion |
| Interest Expense | 2.22 Billion | 1.32 Billion | 765 Million | 1.2 Billion | 1.57 Billion | 2.33 Billion |
| Income Tax Expense | 1.31 Billion | 1.32 Billion | 1.64 Billion | 1.19 Billion | 991 Million | 774 Million |
| Earnings before Tax | 5.71 Billion | 6.55 Billion | 8.13 Billion | 5.98 Billion | 5.6 Billion | 2.77 Billion |
| Net Income | 4.4 Billion | 5.22 Billion | 6.48 Billion | 4.8 Billion | 4.66 Billion | 6.46 Billion |
| Earnings Per Share Basic | 9.91 | 11.77 | 14.32 | 9.66 | 10.64 | 14.16 |
| Earnings Per Share Diluted | 9.91 | 11.77 | 14.32 | 9.66 | 10.64 | 14.16 |
| Weighted Average Shares Outstanding | 444.2 Million | 444.2 Million | 453 Million | 456.5 Million | 456.5 Million | 456.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 444.2 Million | 444.2 Million | 453 Million | 456.5 Million | 456.5 Million | 456.5 Million |
| Gross Margin | 0.44 | 0.45 | 0.47 | 0.47 | 0.50 | 0.51 |
| EBIT Margin | 0.22 | 0.26 | 0.28 | 0.26 | 0.28 | 0.28 |
| Profit Margin | 0.10 | 0.13 | 0.17 | 0.13 | 0.12 | 0.17 |
| EBITDA | 9.9 Billion | 9.5 Billion | 10.48 Billion | 8.66 Billion | 7.26 Billion | 5.54 Billion |
| Earnings Before Tax Margin | 0.16 | 0.19 | 0.22 | 0.19 | 0.18 | 0.12 |
| Breakdown | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 23.56 Billion | 21.14 Billion | 10.57 Billion | 40.7 Billion | 21.55 Billion | 10.77 Billion |
| Cost of Revenue | 13.46 Billion | 11.82 Billion | 5.91 Billion | 22.3 Billion | 11.59 Billion | 5.82 Billion |
| Gross Profit | 10.1 Billion | 9.31 Billion | 4.65 Billion | 18.4 Billion | 9.96 Billion | 4.95 Billion |
| Operating Expenses | 6.6 Billion | 5.81 Billion | 2.92 Billion | 9.46 Billion | 4.8 Billion | 3.08 Billion |
| Selling, General and Administrative Expenses | 5.1 Billion | 4.99 Billion | 2.49 Billion | - | 4.8 Billion | 2.38 Billion |
| Research and Development Expenses | 162 Million | - | - | - | 107 Million | 107 Million |
| Other Expenses | 1.34 Billion | 814 Million | - | - | - | - |
| Cost and Expenses | 20.06 Billion | 17.64 Billion | 8.84 Billion | 31.76 Billion | 16.39 Billion | 8.91 Billion |
| Operating Income | 3.49 Billion | 3.5 Billion | 1.75 Billion | 7.82 Billion | 5.16 Billion | 2.51 Billion |
| Interest Expense | - | 959 Million | - | 1.32 Billion | 829 Million | 234.5 Million |
| Income Tax Expense | 716 Million | 594 Million | 297 Million | 1.32 Billion | 703 Million | 351.5 Million |
| Earnings before Tax | 2.8 Billion | 2.9 Billion | 1.45 Billion | 6.55 Billion | 3.25 Billion | 1.62 Billion |
| Net Income | 2.09 Billion | 2.31 Billion | 1.15 Billion | 5.22 Billion | 2.55 Billion | 1.27 Billion |
| Earnings Per Share Basic | 4.71 | 5.21 | 2.60 | - | 5.75 | 2.87 |
| Earnings Per Share Diluted | 4.71 | 5.21 | 2.60 | - | 5.75 | 2.87 |
| Weighted Average Shares Outstanding | 444.12 Million | 444.31 Million | 444.31 Million | 444.2 Million | 444.23 Million | 444.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 444.1 Million | 444.3 Million | 444.3 Million | 444.2 Million | 444.23 Million | 444.2 Million |
| Gross Margin | 0.43 | 0.44 | 0.44 | 0.45 | 0.46 | 0.46 |
| EBIT Margin | 0.25 | 0.21 | 0.21 | - | 0.28 | 0.25 |
| Profit Margin | 0.09 | 0.11 | 0.11 | 0.13 | 0.12 | 0.12 |
| EBITDA | 5.85 Billion | 4.44 Billion | 2.22 Billion | - | 6.09 Billion | 2.71 Billion |
| Earnings Before Tax Margin | 0.15 | 0.17 | 0.17 | 0.19 | 0.24 | 0.23 |
CLW
601827
2851
IC8
1020
002480